Investigating the impact of metabolic syndrome traits on telomere length: a Mendelian randomization study
Obesity · 2023
DOI: 10.1002/oby.23810 ↗At a glance
Journal article in Obesity, 2023. Written by Nellie Y Loh and 3 co-authors. Institution: Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Major MEDLINE topics: Metabolic Syndrome. Cited 15 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: British Heart Foundation.
Abstract (original language)
Objective
Observational studies have reported bidirectional associations between metabolic syndrome (MetS) traits and short leukocyte telomere length (LTL), a TL marker in somatic tissues and a proposed risk factor for age‐related degenerative diseases. However, in Mendelian randomization studies, longer LTL has been paradoxically associated with higher MetS risk. This study investigated the hypothesis that shorter LTL might be a consequence of metabolic dysfunction.
Methods
This study undertook univariable and multivariable Mendelian randomization. As instrumental variables for MetS traits, all of the genome‐wide significant independent signals identified in genome‐wide association studies for anthropometric, glycemic, lipid, and blood pressure traits conducted in European individuals were used. Summary‐level data for LTL were obtained from a genome‐wide association study conducted in the UK Biobank.
Results
Higher BMI was associated with shorter LTL ( β = −0.039, 95% CI: −0.058 to −0.020, p = 5 × 10 −5 ) equivalent to 1.70 years of age‐related LTL change. In contrast, higher low‐density lipoprotein cholesterol was associated with longer LTL ( β = 0.022, 95% CI: 0.007 to 0.037, p = 0.003) equivalent to 0.96 years of age‐related LTL change. Mechanistically, increased low‐grade systemic inflammation, as measured by circulating C‐reactive protein, and lower circulating linoleic acid levels might link higher BMI to shorter LTL.
Conclusions
Overweight and obesity might promote the development of aging‐related degenerative diseases by accelerating telomere shortening.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
- Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
- Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
- National Institute for Health Research, Oxford Biomedical Research Centre, Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK.
ORCID profiles: Raymond Noordam, Constantinos Christodoulides
Funding
- British Heart Foundation
Cite
APA
Loh, N. Y., Rosoff, D., Noordam, R., & Christodoulides, C. (2023). Investigating the impact of metabolic syndrome traits on telomere length: a Mendelian randomization study. Obesity. https://doi.org/10.1002/oby.23810
Vancouver
Loh NY, Rosoff D, Noordam R, Christodoulides C. Investigating the impact of metabolic syndrome traits on telomere length: a Mendelian randomization study. Obesity. 2023. doi:10.1002/oby.23810
BibTeX
@article{Loh2023,
author = {Loh, Nellie Y and Rosoff, Daniel and Noordam, Raymond and Christodoulides, Constantinos},
title = {Investigating the impact of metabolic syndrome traits on telomere length: a Mendelian randomization study},
journal = {Obesity},
year = {2023},
doi = {10.1002/oby.23810}
}
EUVIMED